about
Intravenous immunoglobulin treatment in a patient with adrenomyeloneuropathyX-linked adrenoleukodystrophy: correlation between Loes score and diffusion tensor imaging parameters.Treatment of an adrenomyeloneuropathy patient with Lorenzo's oil and supplementation with docosahexaenoic acid--a case report.HDAC inhibitor SAHA normalizes the levels of VLCFAs in human skin fibroblasts from X-ALD patients and downregulates the expression of proinflammatory cytokines in Abcd1/2-silenced mouse astrocytes.Silencing of Abcd1 and Abcd2 genes sensitizes astrocytes for inflammation: implication for X-adrenoleukodystrophy.Newborn screening for X-linked adrenoleukodystrophy: further evidence high throughput screening is feasible.Multiple sclerosis in an adrenoleukodystrophy carrier.Peroxisomes and disease - an overview.Oxidative Stress in Patients with X-Linked Adrenoleukodystrophy.Pediatric neurotherapy.X-linked adrenoleukodystrophy presenting as Addison's disease.A case of adrenoleukodystrophy presenting with manic symptoms in a patient on steroids for Addison's disease.Yoga as Therapy for Neurodegenerative Disorders: A Case Report of Therapeutic Yoga for Adrenomyeloneuropathy.Metformin-induced mitochondrial function and ABCD2 up-regulation in X-linked adrenoleukodystrophy involves AMP-activated protein kinase.Haploidentical bone marrow transplantation with post transplant cyclophosphamide for patients with X-linked adrenoleukodystrophy: a suitable choice in an urgent situation.MicroRNA Profiling Identifies miR-196a as Differentially Expressed in Childhood Adrenoleukodystrophy and Adult Adrenomyeloneuropathy.
P2860
Q34421075-B3A69536-79A1-4058-8060-6C0F35850F59Q35124030-F083B289-72D2-4DE0-B3FA-06D656C9BFF7Q35225619-F6030B81-3F98-4EC9-B1EF-E1B2CA6F9F24Q35380239-312DAB0B-5CE5-44CB-928A-8CD7BE7DE54CQ37014934-0F03962C-91A9-478A-B078-0C65B99BC2E8Q37605113-2E27FD88-B9B1-45C2-A26D-220A355C5324Q37694402-A22C3F3E-580A-40BA-AFCC-5D4F16A94A59Q38106959-C01F0311-1A5F-4A48-98B8-C40FCCE617AFQ38546277-8C70F00A-6A8F-4193-9BB8-3F1DF05247A4Q41353400-5080B3B2-C63F-45DE-BB31-D0E81012631DQ41981701-F016B357-497A-4B44-AE5A-A651407C6142Q42327773-BFA6814C-97A0-4229-B198-82C97231C1B2Q43123516-579A4B2C-EF64-41D7-AE3F-226B9FC4EF5DQ48925414-F9099B41-92AE-4DF7-9CB2-A3F73951195AQ50058671-D9C02510-FB34-4B30-90A1-6369DD80D160Q53276010-C55F6C73-D1EC-421A-8EED-26AED1BA7E1D
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Therapy of X-linked adrenoleukodystrophy
@ast
Therapy of X-linked adrenoleukodystrophy
@en
type
label
Therapy of X-linked adrenoleukodystrophy
@ast
Therapy of X-linked adrenoleukodystrophy
@en
prefLabel
Therapy of X-linked adrenoleukodystrophy
@ast
Therapy of X-linked adrenoleukodystrophy
@en
P2860
P1433
P1476
Therapy of X-linked adrenoleukodystrophy
@en
P2093
Hugo W Moser
P2860
P304
P356
10.1016/J.NURX.2006.01.004
P577
2006-04-01T00:00:00Z